{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:41:14Z","timestamp":1794084074446,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaut.2025.103420","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:19:59Z","timestamp":1744777199000},"page":"103420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Treatment of mixed connective tissue disease: A multicenter retrospective study"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-1827","authenticated-orcid":false,"given":"Kevin","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thoreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00e8le","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Goujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bonnotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duhaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahn","family":"Jean-Emmanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hanslik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Regent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dunogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique LE.","family":"Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2025.103420_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00296-023-05300-x","article-title":"Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study","volume":"43","author":"Batu","year":"2023","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2025.103420_bib3","first-page":"660","article-title":"Trigeminal neuropathy as an initial manifestation in pediatric-onset mixed connective tissue disease","volume":"58","author":"Gezgin Y\u0131ld\u0131r\u0131m","year":"2023","journal-title":"Turk Arch Pediatr"},{"key":"10.1016\/j.jaut.2025.103420_bib4","article-title":"Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort","author":"Chevalier","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/annrheumdis-2016-209522","article-title":"Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study","volume":"76","author":"Hetlevik","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib6","first-page":"333","volume":"13","author":"Abdelgalil Ali Ahmed","year":"2021","journal-title":"Incidence and Clinical Pattern of Mixed Connective Tissue Disease in Sudanese Patients at Omdurman Military Hospital: Hospital-Based Study, OARRR"},{"key":"10.1016\/j.jaut.2025.103420_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","article-title":"\u201cTo Be or not to Be,\u201d ten years after: evidence for mixed connective tissue disease as a distinct entity","volume":"41","author":"Cappelli","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103420_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10238-020-00606-7","article-title":"\u201cMixed connective tissue disease\u201d: a condition in search of an identity","volume":"20","author":"Alves","year":"2020","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.121272","article-title":"Clinical course, prognosis, and causes of death in mixed connective tissue disease","volume":"40","author":"Hajas","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib10","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s10067-022-06286-w","article-title":"The enigma of mixed connective tissue disease\u2014challenges in routine care","volume":"41","author":"Wanzenried","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib11","first-page":"2091","article-title":"Interstitial lung disease in patients with mixed connective tissue disease: a retrospective study","volume":"17","author":"Shan","year":"2024","journal-title":"Int. J. Graph Multimed."},{"key":"10.1016\/j.jaut.2025.103420_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000783","article-title":"Mixed connective tissue disease: state of the art on clinical practice guidelines","volume":"4","author":"Chaigne","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2025.103420_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.42075","article-title":"The INBUILD trial investigators, nintedanib in patients with autoimmune disease\u2013related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial","volume":"74","author":"Matteson","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103420_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","article-title":"Mixed connective tissue disease","volume":"30","author":"Gunnarsson","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib17","series-title":"Mixed Connective Tissue Disease and Antinuclear Antibodies","first-page":"23","article-title":"Diagnostic criteria for classification of MCTD","author":"Sharp","year":"1987"},{"key":"10.1016\/j.jaut.2025.103420_bib18","series-title":"Mixed Connective Tissue Disease and Anti-nuclear Antibodies","first-page":"33","article-title":"Classification and diagnostic criteria for mixed connective tissue disease","author":"Alarcon-Segovia","year":"1987"},{"key":"10.1016\/j.jaut.2025.103420_bib19","series-title":"Les Maladies Syst\u00e9miques","first-page":"545","article-title":"Syndrome de Sharp","author":"Kahn","year":"1991"},{"key":"10.1016\/j.jaut.2025.103420_bib20","series-title":"Mixed Connective Tissue Disease and Anti-nuclear Antibodies","first-page":"41","article-title":"Preliminary diagnostic criteria for classification of mixed connective tissue disease","author":"Kasukawa","year":"1987"},{"key":"10.1016\/j.jaut.2025.103420_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib22","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of rheumatology\/European league against rheumatism collaborative initiative: ACR\/EULAR classification criteria for SSc","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103420_bib23","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib24","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American College of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data\u2010driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jaut.2025.103420_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","article-title":"The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index","volume":"76","author":"Valentini","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib28","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib29","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2025.103420_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccm.2019.05.001","article-title":"Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease","volume":"40","author":"Perelas","year":"2019","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jaut.2025.103420_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/ard-2023-225369","article-title":"Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study","volume":"83","author":"Katsumata","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/rheumatology\/ker514","article-title":"GLADEL, Anti-malarials exert a protective effect while Mestizo patients are at increased risk of developing SLE renal disease: data from a Latin-American cohort","volume":"51","author":"Pons-Estel","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2025.103420_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.chest.2017.08.014","article-title":"Pulmonary arterial hypertension associated with systemic lupus erythematosus","volume":"153","author":"Hachulla","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103420_bib36","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/rheumatology\/kez562","article-title":"Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry","volume":"59","author":"Mena-V\u00e1zquez","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ppul.10125","article-title":"Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland","volume":"34","author":"Dinwiddie","year":"2002","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.jaut.2025.103420_bib38","doi-asserted-by":"crossref","unstructured":"N. \u015eenkal, E. Kiyan, A.A. Demir, Y. Yalcinkaya, A. Gul, M. Inan\u00e7, M.L. \u00d6\u00e7al, B. Artim Esen, Interstitial lung disease in patients with systemic lupus erythematosus: a cohort study, Turk. J. Med. Sci. 52 (n.d.) 76\u201382. https:\/\/doi.org\/10.3906\/sag-2109-16.","DOI":"10.3906\/sag-2109-16"},{"key":"10.1016\/j.jaut.2025.103420_bib39","first-page":"76","article-title":"Impact of immunosuppressive treatment on development and survival in systemic sclerosis associated pulmonary arterial hypertension (SSc-PAH)","volume":"9","author":"Rodolfi","year":"2024","journal-title":"Arthritis Rheumatol. suppl"},{"key":"10.1016\/j.jaut.2025.103420_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib41","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"American College of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2025.103420_bib42","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13075-017-1494-7","article-title":"Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study","volume":"19","author":"Reiseter","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103420_bib43","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acr.22872","article-title":"Epidemiology of mixed connective tissue disease, 1985-2014: a population-based study: epidemiology of MCTD","volume":"68","author":"Ungprasert","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2025.103420_bib44","doi-asserted-by":"crossref","first-page":"1454.2","DOI":"10.1136\/annrheumdis-2022-eular.617","article-title":"AB0655 clinical and immunological features of a Portuguese cohort of mixed connective tissue disease","volume":"81","author":"Guimar\u00e3es","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead055","article-title":"In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study","author":"Chaigne","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"Reiseter","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib47","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.36204","article-title":"Interstitial lung disease in mixed connective tissue disease: an advanced search","author":"Santacruz","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2025.103420_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9692030","article-title":"Clinical and immunological profile of mixed connective tissue disease and a Comparison of four diagnostic criteria","volume":"2020","author":"John","year":"2020","journal-title":"International Journal of Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib49","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","article-title":"Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study","volume":"71","author":"Gunnarsson","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2024-226430","article-title":"EULAR recommendations for the treatment of systemic sclerosis: 2023 update","author":"Del Galdo","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib51","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/rheumatology\/kead360","article-title":"Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis","volume":"63","author":"Distler","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103420_bib53","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1253\/circj.CJ-11-0473","article-title":"Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"75","author":"Miyamichi-Yamamoto","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.jaut.2025.103420_bib54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/rheumatology\/kex256","article-title":"Advocating for early interstitial lung disease detection in mixed connective tissue disease","volume":"57","author":"Graney","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","article-title":"Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)","volume":"44","author":"Bodolay","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib56","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"The Lancet Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.202306-1113ST","article-title":"Treatment of systemic sclerosis\u2013associated interstitial lung disease: evidence-based recommendations. An official American thoracic society clinical practice guideline","volume":"209","author":"Raghu","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2025.103420_bib58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrrheum.2018.42","article-title":"Treatment in myositis","volume":"14","author":"Oddis","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib60","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo\u2010phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103420_bib61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-024-03353-2","article-title":"Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome","volume":"26","author":"Narv\u00e1ez","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2025.103420_bib62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2025.103420_bib63","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib64","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/annrheumdis-2020-217481","article-title":"Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sj\u00f6gren syndrome refractory to rituximab alone","volume":"79","author":"Chevalier","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103420_bib65","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/rheumatology\/kem208","article-title":"Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response","volume":"46","author":"Dunkley","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kem003","article-title":"A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy","volume":"46","author":"Haroon","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103420_bib67","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1055\/s-0029-1234008","article-title":"[Severe corticoid-refractory autoimmune thrombocytopenia associated with mixed connective tissue disease (Sharp's syndrome). Treatment with rituximab]","volume":"134","author":"Rudolph","year":"2009","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.jaut.2025.103420_bib68","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/0961203310369145","article-title":"Severe ischemia following treatment with rituximab in a patient with mixed connective tissue disease: an unusual complication","volume":"19","author":"Vela","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2025.103420_bib69","first-page":"S1","article-title":"Evaluating the therapeutic effects of B cell depletion therapy with rituximab in a longitudinal cohort of mixed connective tissue disease patients","author":"Gunnarsson","year":"2012","journal-title":"ACR Meeting Abstracts"},{"issue":"suppl 10","key":"10.1016\/j.jaut.2025.103420_bib70","article-title":"Rituximab in refractory mixed connective tissue disease: an observational study [abstract]","volume":"67","author":"Pascual","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10067-010-1630-0","article-title":"B cell depletion for autoimmune diseases in paediatric patients","volume":"30","author":"Jansson","year":"2011","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2025.103420_bib72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2249.1999.00864.x","article-title":"Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein","volume":"116","author":"Okawa-Takatsuji","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2025.103420_bib73","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2249.2001.01669.x","article-title":"Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases","volume":"126","author":"Okawa-Takatsuji","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2025.103420_bib74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.172.1.709","article-title":"A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen","volume":"172","author":"Greidinger","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103420_bib75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.autrev.2006.08.007","article-title":"Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease","volume":"6","author":"Keith","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2025.103420_bib76","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.4049\/jimmunol.169.6.3429","article-title":"T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein","volume":"169","author":"Greidinger","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2025.103420_bib77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.rdc.2005.04.004","article-title":"Autoantibodies in the pathogenesis of mixed connective tissue disease","volume":"31","author":"Greidinger","year":"2005","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jaut.2025.103420_bib78","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.1780400818","article-title":"Analysis of human t cell and b cell responses against u small nuclear ribonucleoprotein 70-kd, b, and d polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease","volume":"40","author":"Holyst","year":"1997","journal-title":"Arthritis Rheum."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:23:17Z","timestamp":1746166997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":78,"alternative-id":["S0896841125000654"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103420","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of mixed connective tissue disease: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103420"}}